Huaijiang Xiang

684 total citations
19 papers, 452 citations indexed

About

Huaijiang Xiang is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Huaijiang Xiang has authored 19 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Physiology and 4 papers in Immunology. Recurrent topics in Huaijiang Xiang's work include Alzheimer's disease research and treatments (5 papers), interferon and immune responses (3 papers) and Peptidase Inhibition and Analysis (3 papers). Huaijiang Xiang is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), interferon and immune responses (3 papers) and Peptidase Inhibition and Analysis (3 papers). Huaijiang Xiang collaborates with scholars based in China, United States and Czechia. Huaijiang Xiang's co-authors include Li Tan, Ying Li, Dan Li, Cong Liu, Wencheng Xia, Xin Li, Chung‐Kang Peng, Chao Han, Jiali Shen and Ruimin Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Cancer Research.

In The Last Decade

Huaijiang Xiang

17 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huaijiang Xiang China 12 210 85 71 66 55 19 452
Mostafa H. Ahmed United States 12 322 1.5× 75 0.9× 41 0.6× 80 1.2× 76 1.4× 22 605
S.L. Gande Germany 15 475 2.3× 68 0.8× 26 0.4× 72 1.1× 56 1.0× 30 718
Rahul S. Kathayat United States 16 417 2.0× 51 0.6× 67 0.9× 84 1.3× 29 0.5× 18 639
Christopher K. Arnatt United States 17 277 1.3× 58 0.7× 37 0.5× 14 0.2× 37 0.7× 46 543
Pedro Brugarolas United States 13 272 1.3× 30 0.4× 15 0.2× 60 0.9× 10 0.2× 43 573
Piriya Wongkongkathep United States 13 396 1.9× 115 1.4× 218 3.1× 41 0.6× 8 0.1× 28 664
Shunyu Yao China 13 130 0.6× 55 0.6× 18 0.3× 53 0.8× 36 0.7× 27 531
Eva Muñoz Spain 16 761 3.6× 40 0.5× 68 1.0× 39 0.6× 11 0.2× 24 980
Eric E. Boros United States 16 473 2.3× 60 0.7× 28 0.4× 15 0.2× 18 0.3× 36 840
Chi Meng China 16 255 1.2× 27 0.3× 22 0.3× 92 1.4× 19 0.3× 41 661

Countries citing papers authored by Huaijiang Xiang

Since Specialization
Citations

This map shows the geographic impact of Huaijiang Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaijiang Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaijiang Xiang more than expected).

Fields of papers citing papers by Huaijiang Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huaijiang Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaijiang Xiang. The network helps show where Huaijiang Xiang may publish in the future.

Co-authorship network of co-authors of Huaijiang Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Huaijiang Xiang. A scholar is included among the top collaborators of Huaijiang Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huaijiang Xiang. Huaijiang Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sun, Hao, Yi Jiang, Xinyi Wu, et al.. (2025). RIPK1 Drives JAK1‐STAT3 Signaling to Promote CXCL1‐Mediated Neutrophil Recruitment in Sepsis‐Induced Lung Injury. Advanced Science. 12(45). e07123–e07123.
2.
Zhou, Yuzheng, Taijie Guo, Xiao Zhang, et al.. (2025). Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model. Acta Pharmaceutica Sinica B. 16(1). 387–405.
3.
Tao, Youqi, Qinyue Zhao, Wencheng Xia, et al.. (2024). Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils. Proceedings of the National Academy of Sciences. 121(35). e2321633121–e2321633121. 4 indexed citations
4.
Zhang, Shenqing, Huaijiang Xiang, Youqi Tao, et al.. (2024). Inhibitor Development for α-Synuclein Fibril’s Disordered Region to Alleviate Parkinson’s Disease Pathology. Journal of the American Chemical Society. 146(41). 28282–28295. 14 indexed citations
5.
Zhang, Jingjing, Xiaohui Liu, Jingjing Chen, et al.. (2024). A novel BODIPY-based theranostic agent for in vivo fluorescence imaging of cerebral Aβ and ameliorating Aβ-associated disorders in Alzheimer's disease transgenic mice. RSC Medicinal Chemistry. 15(4). 1216–1224. 1 indexed citations
6.
Cheng, Yan, Lin Cheng, Ying Qin, et al.. (2023). Selective Covalent Targeting of Pyruvate Kinase M2 Using Arsenous Warheads. Journal of Medicinal Chemistry. 66(4). 2608–2621. 10 indexed citations
7.
Xiang, Huaijiang, Zhenfeng Zhang, Mei‐Chun Cai, et al.. (2023). Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer. Science Advances. 9(47). eadj0123–eadj0123. 9 indexed citations
8.
Tao, Youqi, Wencheng Xia, Qinyue Zhao, et al.. (2023). Structural mechanism for specific binding of chemical compounds to amyloid fibrils. Nature Chemical Biology. 19(10). 1235–1245. 36 indexed citations
9.
Qin, Ying, Dekang Li, Chunting Qi, et al.. (2023). Structure-based development of potent and selective type-II kinase inhibitors of RIPK1. Acta Pharmaceutica Sinica B. 14(1). 319–334. 7 indexed citations
10.
Cheng, Lin, Kaixuan Shi, Yan Cheng, et al.. (2022). Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. Cancer Research. 82(19). 3588–3602. 25 indexed citations
11.
Dong, Kangyun, Ran Wei, Taijie Jin, et al.. (2022). HOIP modulates the stability of GPx4 by linear ubiquitination. Proceedings of the National Academy of Sciences. 119(44). e2214227119–e2214227119. 34 indexed citations
12.
Han, Chao, Zhenfeng Zhang, Jiali Shen, et al.. (2022). Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry. 65(20). 13645–13659. 14 indexed citations
13.
Liu, Jianping, Jiali Shen, Jialin Dai, et al.. (2021). Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Cell chemical biology. 28(6). 855–865.e9. 63 indexed citations
14.
Jiang, Xuefeng, Huaijiang Xiang, Ning Wang, et al.. (2020). An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury. Biosensors and Bioelectronics. 172. 112756–112756. 42 indexed citations
15.
Gu, Jinge, Zhenying Liu, Shengnan Zhang, et al.. (2020). Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles. Proceedings of the National Academy of Sciences. 117(49). 31123–31133. 78 indexed citations
16.
Lei, Yu L., Chengkun Wang, Rongrong Tao, et al.. (2019). Visualizing Autophagic Flux during Endothelial Injury with a Pathway-Inspired Tandem-Reaction Based Fluorogenic Probe. Theranostics. 9(19). 5672–5680. 15 indexed citations
17.
Zhang, Jingjing, Cheng Peng, Huaijiang Xiang, et al.. (2018). Fluorescent Imaging of β-Amyloid Using BODIPY Based Near-Infrared Off–On Fluorescent Probe. Bioconjugate Chemistry. 29(10). 3459–3466. 52 indexed citations
18.
Xiang, Huaijiang, Chung‐Kang Peng, Jingjing Chen, et al.. (2018). Direct C–H functionalization of difluoroboron dipyrromethenes (BODIPYs) at β-position by iodonium salts. RSC Advances. 8(10). 5542–5549. 21 indexed citations
19.
Xu, Mingming, Steven H. Liang, Huaijiang Xiang, et al.. (2015). Discovery of a novel fluorescent probe for the sensitive detection of β-amyloid deposits. Biosensors and Bioelectronics. 75. 136–141. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mostafa H. Ahmed Breakdown of academic impact, for papers by S.L. Gande Breakdown of academic impact, for papers by Rahul S. Kathayat Breakdown of academic impact, for papers by Christopher K. Arnatt Breakdown of academic impact, for papers by Pedro Brugarolas Breakdown of academic impact, for papers by Piriya Wongkongkathep Breakdown of academic impact, for papers by Shunyu Yao Breakdown of academic impact, for papers by Eva Muñoz Breakdown of academic impact, for papers by Eric E. Boros Breakdown of academic impact, for papers by Chi Meng
Rankless by CCL
2026